South Africa
Dec 11, 2024
Authors: Brenda Gati Mirembe, Deborah Donnell, Meighan Krows, Zinhle Zwane, Elizabeth Bukusi, Ravindre Panchia, Cheryl Louw, Noluthando Mwelase, Pearl Selepe, Melissa Senne, Logashvari Naidoo, Rachel Chihana, Margaret Kasaro, Harriet Nuwagaba-Biribonwoha, Philip...
Nov 25, 2024
Authors:Â Brenner IR, Flanagan CF, Penazzato M, Webb KA, Horsfall SB, Hyle EP, Abrams E, Bacha J, Neilan AM, Collins IJ, Desmonde S, Crichton S, Davies MA, Freedberg KA, Ciaranello AL. Abstract: Background For children with HIV on antiretroviral therapy (ART),...
Oct 28, 2024
Article and Study Summary: Article Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women Published in: N Engl J Med. 2024;391(13):1179–1192. https://doi.org/10.1056/NEJMoa2407001 Authors: Bekker L, Das M, Abdool Karim Q, et al. for the PURPOSE...
Oct 2, 2024
The HIV Impact Network for Vertical Transmission Elimination (HIVE) is a multi-country knowledge-exchange network. HIVE collaborates with ministries of health and partner organizations in the vertical transmission prevention response, including networks of people...
Aug 27, 2024
Authors:Â Abrams EJ, Jao J, Madlala HP, Zerbe A, Catalano P, Gerschenson M, Goedecke JH, Gomba Y, Josefson J, Kurland IJ, Legbedze J, McComsey GA, Matyesini S, Mukonda E, Robinson D, Myer L. Abstract:Â Introduction Dolutegravir (DTG)-based antiretroviral therapy is...